Back
Johnson Outdoors Vs. Blueprint Medicines Industry Stock Comparison
Sell
20
JOUT
Johnson Outdoors
Last Price:
$33.13
Seasonality Move:
3.33%
Sell
43
BPMC
Blueprint Medicines
Last Price:
$102.47
Seasonality Move:
5.27%
Sell
20
Johnson Outdoors (JOUT)
is a Sell
Is Johnson Outdoors a Buy, Sell or Hold?
-
The current Johnson Outdoors [JOUT] share price is $32.94. The Score for JOUT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
JOUT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $103.36. The Score for BPMC is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JOUT Stock Price Chart
What is Johnson Outdoors's stock price today?
-
The Johnson Outdoors share price today is $32.94Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JOUT is experiencing slight buying pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $103.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
JOUT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.24 | Sell |
Relative Strength Index (14 RSI): | 42.66 | Sell |
Chaikin Money Flow: | 5018 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.35 - 36.53) | Sell |
Bollinger Bands (100): | (33.06 - 36.38) | Sell |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 65.19 | Buy |
Chaikin Money Flow: | 1951173 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.25 - 95.81) | Buy |
Bollinger Bands (100): | (87.04 - 95.76) | Buy |
JOUT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.9 | Sell |
20-day SMA: | 35.1 | Sell |
50-day SMA: | 34.07 | Sell |
200-day SMA: | 36.53 | Sell |
8-day EMA: | 33.93 | Sell |
20-day EMA: | 34.35 | Sell |
50-day EMA: | 34.44 | Sell |
200-day EMA: | 37.57 | Sell |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 91.01 | Buy |
20-day SMA: | 91.26 | Buy |
50-day SMA: | 93.56 | Buy |
200-day SMA: | 96.81 | Buy |
8-day EMA: | 92.7 | Buy |
20-day EMA: | 91.91 | Buy |
50-day EMA: | 92.32 | Buy |
200-day EMA: | 91.6 | Buy |
Johnson Outdoors Earnings Growth & JOUT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $2.45 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.
Johnson Outdoors Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |